Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications

Tanner M. Johanns; Jay A. Bowman-Kirigin; Connor Liu; Gavin P. Dunn

doi:10.1093/neuros/nyx321

Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications

Tanner M. Johanns
, Jay A. Bowman-Kirigin
, Connor Liu
, Gavin P. Dunn

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	165-176
Number of pages	12
Journal	Clinical neurosurgery
Volume	64
Issue number	CN
DOIs	https://doi.org/10.1093/neuros/nyx321
State	Published - Sep 1 2017

Access to Document

10.1093/neuros/nyx321

Cite this

@article{b3d6098ba7524ac18911f99e82e6ee79,

title = "Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications",

author = "Johanns, \{Tanner M.\} and Bowman-Kirigin, \{Jay A.\} and Connor Liu and Dunn, \{Gavin P.\}",

note = "Funding Information: Dr Dunn is a cofounder of Immunovalent Therapeutics. This study was funded by National Institutes of Health grant K08NS092912 (G.P.D.), American Cancer Society-Institutional Research grant (G.P.D), the Physician-Scientist Training Program (T.M.J.), and the Medical Scientist Training Program (J.B.K.) at Washington University School of Medicine. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.",

year = "2017",

month = sep,

day = "1",

doi = "10.1093/neuros/nyx321",

language = "English",

volume = "64",

pages = "165--176",

journal = "Clinical neurosurgery",

issn = "0069-4827",

number = "CN",

}

TY - JOUR

T1 - Targeting Neoantigens in Glioblastoma

T2 - An Overview of Cancer Immunogenomics and Translational Implications

AU - Johanns, Tanner M.

AU - Bowman-Kirigin, Jay A.

AU - Liu, Connor

AU - Dunn, Gavin P.

N1 - Funding Information: Dr Dunn is a cofounder of Immunovalent Therapeutics. This study was funded by National Institutes of Health grant K08NS092912 (G.P.D.), American Cancer Society-Institutional Research grant (G.P.D), the Physician-Scientist Training Program (T.M.J.), and the Medical Scientist Training Program (J.B.K.) at Washington University School of Medicine. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.

PY - 2017/9/1

Y1 - 2017/9/1

UR - https://www.scopus.com/pages/publications/85042131370

U2 - 10.1093/neuros/nyx321

DO - 10.1093/neuros/nyx321

M3 - Article

C2 - 28899059

AN - SCOPUS:85042131370

SN - 0069-4827

VL - 64

SP - 165

EP - 176

JO - Clinical neurosurgery

JF - Clinical neurosurgery

IS - CN

ER -

Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications

Access to Document

Other files and links

Cite this